melanoma
75 projects
H2020Individual fellowship2020–2022Israel
MelImmuneOrg · Deciphering the tumor-immune-microenvironment profile and organization within the tumors of melanoma patients undergoing immunotherapy
H2020Individual fellowship2020–2022Netherlands
UNPACK PD-L1 · Molecular mechanism and inhibition of extracellular vesicle-mediated PD-L1 release in melanoma cells
H2020Individual fellowship2019–2021Denmark
ARGONAUT · from the synthesis of gAnglioside tumouR antiGens to a platfOrm for caNcer Active immUnoTherapy
H2020Individual fellowship2019–2021Belgium
INHuMAN · Intra-tumoral heterogeneity in NRAS-driven metastatic melanoma
H2020Individual fellowship2018–2020Netherlands
KILNEV · Killing Senescent Cells as a Novel Method to Eliminate Nevi
H2020Individual fellowship2018–2020Denmark
UTILIUM · Unraveling The Immune Landscape In Uveal Melanoma
H2020Individual fellowship2018–2020Spain
IMMUNOMARK · Omics integration for precision cancer immunotherapy
H2020Individual fellowship2018–2020Spain
CINK · Advancing cancer immunotherapy using natural killer cells for hematological and metastatic cancers
H2020Individual fellowship2018–2020Portugal
TRIBBLES · Characterizing the clinical relevance and the mechanism underlying TRIB2-mediated drug resistance to MEK inhibitiors in the context of melanoma
H2020Individual fellowship2017–2021Spain
METMEL · Long range-acting drivers of premetastatic niches in melanoma
H2020Individual fellowship2017–2019Ireland
SAMNets · Investigation of adaptive design and rewiring of Survival-Apoptosis-Mitogenic (SAM) signalling transduction network
H2020Individual fellowship2017–2019Israel
SCALTIE · Single cell analysis of the lung tumour-immune ecosystem: Developing new tools for effective immunotherapy
H2020Staff exchange2017–2023Spain
MAGNAMED · Novel magnetic nanostructures for medical applications
18 partners · 8 countries
H2020Individual fellowship2017–2018Spain
DLL4-LVN · Targeting the (pre)metastatic lympho-vascular niche: molecular mechanisms and therapeutic implications in melanoma
H2020Individual fellowship2017–2019France
MCNTMTDC · Metabolic control on NF-κB activity during dendritic cells-mediated immune tolerance to tumours
H2020Individual fellowship2016–2018United Kingdom
GENMETASTEM · GENOMIC AND METABOLIC REGULATION OF METASTATIC CANCER STEM CELLS
H2020Doctoral network2015–2019Ireland
TRAIN-ERS · Endoplasmic Reticulum Stress in Health and Disease
18 partners · 11 countries
H2020Doctoral network2015–2019United Kingdom
MELGEN · MELanoma GENetics - understanding and biomarking the genetic and immunological determinants of melanoma survival
6 partners · 5 countries
H2020Doctoral network2015–2019Netherlands
VIRION · Viruses, Immune stimulation and RNA Interference in Oncology Network
9 partners · 4 countries
H2020Individual fellowship2015–2017Denmark
MatrixMacrophages · Matrix degrading macrophages in cancer growth and invasion
H2020Individual fellowship2015–2017United Kingdom
MELANOPARK · Investigating the LRRK2-melanin connection through phosphoproteomics of isogenic melanoma cells
H2020Individual fellowship2015–2017United Kingdom
Tolltum · Role, regulation and targeting of nucleic acid-sensing TLRs within the tumour microenvironment
H2020Staff exchange2014–2018Germany
SAGE-CARE · SemAntically integrating Genomics with Electronic health records for Cancer CARE
5 partners · 5 countries
H2020Doctoral network2014–2018Ireland
MEL-PLEX · Exploiting MELanoma disease comPLEXity to address European research training needs in translational cancer systems biology and cancer systems medicine
20 partners · 11 countries